MYUNGMOON Pharm co.,Ltd (KRX:017180)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,655.00
-13.00 (-0.78%)
Last updated: Apr 28, 2025

MYUNGMOON Pharm co.,Ltd Revenue

In the year 2024, MYUNGMOON Pharm co.,Ltd had annual revenue of 186.44B KRW with 9.95% growth. MYUNGMOON Pharm co.,Ltd had revenue of 49.15B in the quarter ending December 31, 2024, with 14.70% growth.

Revenue
186.44B
Revenue Growth
+9.95%
P/S Ratio
0.29
Revenue / Employee
661.15M
Employees
282
Market Cap
53.92B

Revenue Chart

Created with Highcharts 11.4.8MYUNGMOON Pharm co.,Ltd Revenue - Annual127.9B127.9B137.8B137.8B152.1B152.1B169.6B169.6B186.4B186.4B20202021202220232024-50B100B150B200B

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024186.44B16.88B9.95%
Dec 31, 2023169.57B17.43B11.46%
Dec 31, 2022152.13B14.38B10.43%
Dec 31, 2021137.76B9.91B7.75%
Dec 31, 2020127.85B-21.49B-14.39%
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Samsung Biologics 4,547.32B
Celltrion 3,557.30B
ALTEOGEN 102.85B
Yuhan 2,067.79B
SK Biopharmaceuticals 547.60B
HLB Co., Ltd. 68.13B
PharmaResearch 350.12B
Peptron 3.15B
Revenue Rankings